公司摊薄每股收益为0.03元，较去年同报告期摊薄每股收益增加0.02元，实现4年连续上涨，同比较去年同期上涨200.00%。 公司最新总资产周转率为0.18次，较去年同期总资产周转率增加0.01次，实现4年连续上涨，同比较去年同期上涨7.34%。最新存货周转率为0.97次，较去年 同期存货周转率增加0.24次，实现4年连续上涨，同比较去年同期上涨33.93%。 公司股东户数为1.11万户，前十大股东持股数量为1.53亿股，占总股本比例为36.89%，前十大股东持股情况如下： | 序号 | 股东名称 | 持股 | | --- | --- | --- | | 1 | 天津佳信阳光企业管理咨询有限公司 | 17.2 | | 2 | 郭彦超 | 5.47 | | 3 | 黄松浪 | 2.62 | | ব | 天津阳光广业企业管理合伙企业(有限合伙) | 2.55 | | 5 | 天津阳光德业企业管理合伙企业(有限合伙) | 1.97 | | 6 | 李广欣 | 1.89 | | 【 | 天津阳光永业企业管理合伙企业(有限合伙) | 1.61 | | 8 | 北京时代复兴投资管理有限公司-时代复兴太平1号私募证券投资基 ...

公募基金方面，本期较上一季度新披露的公募基金共计1个，即中金中证500指数增强A。本期较上一季 未再披露的公募基金共计1个，即信澳中小盘混合A。 2025年8月22日，赛诺医疗(688108.SH)发布2025年半年度报告。截至2025年8月21日，共有7个机构投资 者披露持有赛诺医疗A股股份，合计持股量达1.07亿股，占赛诺医疗总股本的25.76%。其中，机构投资 者包括天津伟信阳光企业管理咨询有限公司、天津阳光广业企业管理合伙企业(有限合伙)、天津阳光德 业企业管理合伙企业(有限合伙)、天津阳光永业企业管理合伙企业(有限合伙)、北京时代复兴投资管理 有限公司-时代复兴太平1号私募证券投资基金、北京和聚私募基金管理有限公司-和聚世然1期私募证券 投资基金、中金中证500指数增强A，机构投资者合计持股比例达25.76%。相较于上一季度，机构持股 比例合计下跌了0.32个百分点。 ...

Policy Developments - The State Council has agreed in principle to the "Biopharmaceutical Industry Chain Open Innovation Development Plan" for the China (Jiangsu) Free Trade Zone, aiming to create a globally influential biopharmaceutical industry hub and enhance international competitiveness [1] Industry Initiatives - The National Health Commission has issued guidelines to promote the application of artificial intelligence in ear and hearing health, focusing on the development and transformation of cutting-edge technologies in the field [2] Medical Pricing Guidelines - The National Medical Insurance Administration has released two project guidelines for medical service pricing, including the "Hernia and Thyroid Medical Service Pricing Project" and the "Digestive System Medical Service Pricing Project," integrating existing pricing projects into 25 and 150 items respectively [3] Medical Device Approvals - Zhonghong Medical's subsidiary, Shenzhen Maide Rui Na, has obtained a medical device registration certificate for an infusion pump, valid until August 19, 2030 [4] - Zhejiang Medicine has received approval for clinical trials of XC2309 injection, a first-class chemical drug intended for treating gastrointestinal ulcer bleeding [5] Financial Performance - Maipu Medical reported a 29.28% increase in revenue to 158 million yuan and a 46.03% rise in net profit to 47.3 million yuan for the first half of 2025 [6] - Sainuo Medical achieved a 12.53% increase in revenue to 240 million yuan and a remarkable 296.54% growth in net profit to 13.8 million yuan in the same period [8] - Baihua Medicine reported a revenue of 202 million yuan, a 2.95% increase, and a net profit of 25.5 million yuan, up 12.45% [9] Capital Market Activities - Linuo Pharmaceutical plans to acquire a 30% stake in Suzhou Chuangyang New Materials Technology Co., Ltd. for 84 million yuan [10] Industry Innovations - Researchers from Columbia University and Rockefeller University have developed a new therapy using bacteria to deliver viruses directly to tumors, enhancing cancer treatment efficacy [11] - Sanbo Brain Science has begun using surgical robots in certain neurosurgical procedures to improve service quality and surgical outcomes [12] Corporate Changes - Yiming Pharmaceutical announced a change in its actual controller to Yao Jinbo, following a share transfer from the previous controller [13] - Tiantan Biological received a commitment from its actual controller to resolve newly created competition issues due to a recent acquisition [14]

| 股票名称 | 监控开始日期 监控结束日期 异动开始日期 | | | --- | --- | --- | | *ST苏吴 | 2025-08-21 2025-09-03 未披露 | | | 600200 | | | | 赛诺医疗 | 2025-08-19 2025-09-01 2025-08-07 | | | 688108 | | | | 东芯股份 | 2025-08-18 2025-08-29 2025-07-07 | | | 688110 | | | | 赛诺医疗 | 2025-08-18 2025-08-29 2025-08-07 | | | 688108 | | | | 淳中科技 | 2025-08-15 2025-08-28 未披露 | | | 603516 | | | | 长城军工 | 2025-08-14 2025-08-27 2025-07-31 | | | 601606 | | | | 赛诺医疗 | 2025-08-14 2025-08-27 | 2025-08-07 | | 688108 | | | *免责声明：文章内容仅供参考，不构成投资建议 *风险提示：股市有风险，入市需谨慎 ...

公司代码：688108 公司简称：赛诺医疗 1.2重大风险提示 公司已在本报告中详细阐述了公司在经营过程中可能面临的各种风险及应对措施，具体内容详见本报告 第三节"管理层讨论与分析之风险因素"部分的阐述，敬请投资者注意投资风险。 1.3本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、完整 性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 1.4公司全体董事出席董事会会议。 1.5本半年度报告未经审计。 1.6董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 第一节 重要提示 1.1本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规 划，投资者应当到www.sse.com.cn网站仔细阅读半年度报告全文。 1.7是否存在公司治理特殊安排等重要事项 □适用 √不适用 第二节 公司基本情况 2.1公司简介 公司股票简况 ■ 公司存托凭证简况 □适用 √不适用 联系人和联系方式 ■ 2.2主要财务数据 单位：元 币种：人民币 ■ 2.6截至报告期末的优先股股东总数、前10名优先股股东情况表 ■■ 2.3前10名股东持 ...

（文章来源：证券日报） 证券日报网讯 8月21日晚间，赛诺医疗发布公告称，2025年半年度公司实现营业收入240，476，013.66 元，同比增长12.53%；归属于上市公司股东的净利润为13，841，586.81元，同比增长296.54%。 ...

今日焦点 弘信电子公告称，2025年上半年，公司实现营业收入34.94亿元，同比增长15.01%，归母净利润5399.31 万元，同比增长9.85%。FPC业务单季度首次实现扭亏为盈，成为公司业绩重要的增长点。报告期内， 公司的液冷漏液监测FPC应用方案顺利取得某头部AI算力服务器散热客户的订单，已经量产并出货，未 来双方将进一步达成深度战略合作。 20CM涨停三未信安：上半年净亏损2938.58万元 三未信安公告称，2025年上半年公司营业收入为1.95亿元，同比增长15.19%，净亏损2938.58万元，上 年同期为盈利1370.93万元。公司在原生云密码服务、低空飞行安全和抗量子密码产品等研发项目上有 较大投入，同时在Web3.0（RWA、区块链等）和AI等新兴领域加大人才储备。 金杯电工：孙公司签订厂房购买协议，欧洲基地建设取得实质性进展 金杯电工公告称，公司全资孙公司GoldCupTolyEuropeElectromagneticWires.r.o.与捷克公司Solwings.r.o. 签订了厂房《购买协议》，购买金额为2,996,000欧元（不含增值税）。该协议的达成标志着公司欧洲生 产基地建设取 ...

赛诺医疗表示，报告期内，冠脉介入业务营业收入同比增长17.4%，主要系本报告期两款进入集采范围 的冠脉支架产品销量和冠脉球囊产品销量大幅增长影响所致；神经介入业务营业收入同比增长6.25%， 主要系本报告期上年新上市销售的产品销量增长影响所致。 值得一提的是，赛诺医疗系8月大牛股，8月以来股价涨幅一度接近两倍。近三个交易日，赛诺医疗股价 出现回调，截至8月21日收盘，赛诺医疗报34.22元/股，跌幅为8.21%。 北京商报讯（记者 丁宁）8月21日晚间，赛诺医疗（688108）披露2025年半年度报告显示，公司上半年 实现营业收入2.4亿元，同比增长12.53%；归属净利润1384.16万元，同比增长296.54%。 ...

Growth - Teva Pharmaceutical reported a net profit of 38.01 million yuan in the first half of the year, a year-on-year increase of 1313.23% [1] - Qianfang Technology achieved a net profit of 170 million yuan, up 1287.12% year-on-year [1] - Tianyu Digital Science and Technology recorded a net profit of 23.62 million yuan, reflecting a 453.67% increase [1] - Suzhou Gude reported a net profit of 43.70 million yuan, up 310.28% year-on-year [1] - Sainuo Medical achieved a net profit of 13.84 million yuan, an increase of 296.54% [1] - Runfeng Co., Ltd. reported a net profit of 556 million yuan, up 205.62% year-on-year [1] - Guodian Nanzi achieved a net profit of 159 million yuan, reflecting a 197.03% increase [1] - Ruijie Networks reported a net profit of 452 million yuan, up 194% year-on-year [1] - Zhongjing Technology achieved a net profit of 25.74 million yuan, an increase of 144.05% [1] - China National Materials Technology reported a net profit of 999 million yuan, up 114.92% year-on-year [1] - Lante Optics achieved a net profit of 103 million yuan, reflecting a 110.27% increase [1] - Yidao Information reported a net profit of 11.41 million yuan, up 96.02% year-on-year [1] - Qianzhao Optoelectronics achieved a net profit of 69.23 million yuan, an increase of 88.04% [1] - Ruile New Materials reported a net profit of 166 million yuan, up 74.22% year-on-year [1] - Lvtian Machinery achieved a net profit of 140 million yuan, reflecting a 64.36% increase [1] - Mega Chip Color reported a net profit of 110 million yuan, up 48.83% year-on-year [1] - Jiaojian Co., Ltd. achieved a net profit of 113 million yuan, an increase of 48.66% [1] - Huhua Electronics reported a net profit of 1.683 billion yuan, up 47.50% year-on-year [1] - Sany Heavy Industry achieved a net profit of 5.216 billion yuan, reflecting a 46% increase [1] - Goodix Technology reported a net profit of 431 million yuan, up 35.74% year-on-year [1] - Allwinner Technology achieved a net profit of 161 million yuan, an increase of 35.36% [1] - Bichu Electronics reported a net profit of 640 million yuan, up 30.32% year-on-year [1] - Ganneng Co., Ltd. achieved a net profit of 438 million yuan, reflecting a 29.39% increase [1] - Weigao Medical reported a net profit of 492 million yuan, up 28.07% year-on-year [1] - GoerTek achieved a net profit of 1.417 billion yuan, reflecting a 15.65% increase [1] - Huason Pharmaceutical reported a net profit of 53.95 million yuan, up 14.27% year-on-year [1] - Gaoxin Development achieved a net profit of 66.92 million yuan, an increase of 14.06% [1] - Shanghai Jahwa reported a net profit of 266 million yuan, up 11.66% year-on-year [1] Stable Growth - Hangcha Group reported a net profit of 1.121 billion yuan, reflecting an increase of 11.38% year-on-year [2] - Dong'e Ejiao achieved a net profit of 818 million yuan, up 10.74% [2] - Beikong Technology reported a net profit of 54.31 million yuan, an increase of 10.59% [2] - Hongxin Electronics achieved a net profit of 53.99 million yuan, up 9.85% year-on-year [2] - Huace Testing reported a net profit of 467 million yuan, reflecting a 7.03% increase [2] - Samsung Medical achieved a net profit of 1.230 billion yuan, up 6.93% year-on-year [2] - Jiangzhong Pharmaceutical reported a net profit of 522 million yuan, reflecting a 5.80% increase [2] - Hualing Cable achieved a net profit of 63.64 million yuan, up 4.74% year-on-year [2] - Kuaijishan reported a net profit of 93.88 million yuan, reflecting a 3.41% increase [2] - Laishen Tongling achieved a net profit of 60.61 million yuan, turning from loss to profit [2] - Yunnan Geology reported a net profit of 22.15 million yuan, turning from loss to profit [2] - Shandong Steel achieved a net profit of 1.253 million yuan, turning from loss to profit [2] Decline and Loss - Zhongtian Rocket reported a net profit of 394,460 yuan, a year-on-year decrease of 80.74% [2] - Liuhua Co., Ltd. achieved a net profit of 344,280 yuan, down 78.01% year-on-year [2] - Qiaqia Food reported a net profit of 886.42 million yuan, a decrease of 73.68% [2] - Hangjin Technology achieved a net profit of 1.372 million yuan, down 58.38% year-on-year [2] - Taiping Bird reported a net profit of 7.771 million yuan, a decrease of 54.61% [2] - Canadian Solar reported a net profit of 731 million yuan, down 41.01% year-on-year [2] - Sinopec achieved a net profit of 21.483 billion yuan, a decrease of 39.8% [2] - Fulejia reported a net profit of 230 million yuan, down 32.54% year-on-year [2] - Palin Bio reported a net profit of 236 million yuan, down 27.89% [2] - Yiwei Lithium Energy achieved a net profit of 1.605 billion yuan, down 24.9% year-on-year [2] - Jinguang Electric reported a net profit of 42.34 million yuan, down 17.16% [2] - Hexing Co., Ltd. achieved a net profit of 107 million yuan, down 16.98% year-on-year [2] - Electric Investment Production and Financing reported a net profit of 459 million yuan, down 13.41% [2] - Tiantan Biological achieved a net profit of 633 million yuan, down 12.88% year-on-year [2] - Huali Group reported a net profit of 1.671 billion yuan, down 11.06% [2] - Zhongyou Engineering achieved a net profit of 470 million yuan, down 10.87% year-on-year [2] Further Losses - Chongda Technology reported a net profit of 222 million yuan, down 6.19% year-on-year [3] - Xinhua Department Store achieved a net profit of 86.01 million yuan, down 2.52% [3] - Zhuosheng Micro reported a net loss of 147 million yuan, turning from profit to loss [3] - Penghui Energy reported a net loss of 88.23 million yuan, turning from profit to loss [3] - Yipin Hong reported a net loss of 73.54 million yuan, turning from profit to loss [3] - Zhongbing Hongjian reported a net loss of 40.71 million yuan, turning from profit to loss [3] - Sanwei Xinan reported a net loss of 29.39 million yuan, turning from profit to loss [3] - Anyuan Coal reported a net loss of 290 million yuan [3] - Keda Xunfei reported a net loss of 239 million yuan [3] - Jishi Media reported a net loss of 23.2 million yuan [3] - Nanjing Chemical Fiber reported a net loss of 88.93 million yuan [3] - Guangsheng Tang reported a net loss of 66.69 million yuan [3] - Chutian Long reported a net loss of 39.77 million yuan [3]

每经AI快讯，赛诺医疗（SH 688108，收盘价：34.22元）8月21日晚间发布公告称，公司第三届第六次 董事会会议于2025年8月21日在北京市海淀区高梁桥斜街59号中坤大厦7层公司会议室召开。会议审议了 《关于赛诺医疗科学技术股份有限公司2025年半年度报告及其摘要的议案》等文件。 每经头条（nbdtoutiao）——核心产品净值仅剩7毛钱，昔日"公募一哥"任泽松怎么了？牛市踏空真相曝 光 （记者 王晓波） 截至发稿，赛诺医疗市值为142亿元。 2024年1至12月份，赛诺医疗的营业收入构成为：医疗器械行业占比99.83%，其他业务占比0.17%。 ...